TFPI and Venous thrombosis: Under these circumstances, the tissue factor pathway inhibitor (TFPI)/protein S anticoagulant system is a major determinant of TG, and the designated assay known as the normalised APC sensitivity ratio (nAPCsr) was clinically validated through a strong association with multiple hereditary and acquired risk factors for venous thrombosis.11, 12